Kailasanath Quoted in Biocentury on IP Strategies for Digital Therapeutics

Senior associate Vinita Kailasanath was quoted in a recent BioCentury article titled "Navigating IP Strategies in the World of Digital Therapeutics." The article examines how evolving IP strategies for digital therapeutics will need to balance the competing interests of the life sciences and technology sectors.

» Read the full article (subscription required).